Full title: Towards a DMaTrix machine – Developing DMT as a technology for communication with interdimensional alien intelligences
If we are to take seriously the idea that DMT grants access to alternate realities populated by conscious intelligent beings, and if we wish to establish and maintain stable communication with these entities, we need to develop DMT as a technology fit for purpose. The most popular modes of administration of purified DMT – vaporisation in a glass pipe or modified e-cigarette or bolus IV injection – are efficient but deliver an extremely time-limited journey into the DMT space. This often frustrates the voyager by dragging them out of the space just as it begins to stabilize and before stable bipartite communication with intelligences can be initiated.
I will discuss how we can move beyond the glass pipe and bolus injection and explore 21st century techniques for extending the DMT state from the order of minutes to the order of hours or even days. Repurposing techniques from modern anaesthesiology, I will explain how target-controlled intravenous infusion can be used to reach and maintain a stable concentration of DMT in the brain over extended periods, allowing a subject to be brought into the DMT space and held there for a theoretically unlimited period of time. In the future, I envisage a DMaTrix machine beside which an individual will lie down and insert a canula, input a desired journey time, and set off for the universe next door.
Dr. Andrew Gallimore is a computational neurobiologist, pharmacologist, chemist, and writer who has been interested in the neural basis of psychedelic drug action for many years and is the author of a number of articles and research papers on the powerful psychedelic drug, N,N-dimethyltryptamine (DMT), as well as the book Alien Information Theory: Psychedelic Drug Technologies and the Cosmic Game (April 2019).
He recently collaborated with DMT pioneer Dr. Rick Strassman, author of DMT: The Spirit Molecule, to develop a pharmacokinetic model of DMT as the basis of a target-controlled intravenous infusion protocol for extended journeys in DMT space. His current interests focus on DMT as a tool for gating access to extradimensional realities and how this can be understood in terms of the neuroscience of information. He currently lives and works in Japan.
